NZ Herald
  • Home
  • Latest news
  • Herald NOW
  • Video
  • New Zealand
  • Sport
  • World
  • Business
  • Entertainment
  • Podcasts
  • Quizzes
  • Opinion
  • Lifestyle
  • Travel
  • Viva
  • Weather

Subscriptions

  • Herald Premium
  • Viva Premium
  • The Listener
  • BusinessDesk

Sections

  • Latest news
  • New Zealand
    • All New Zealand
    • Crime
    • Politics
    • Education
    • Open Justice
    • Scam Update
  • Herald NOW
  • On The Up
  • World
    • All World
    • Australia
    • Asia
    • UK
    • United States
    • Middle East
    • Europe
    • Pacific
  • Business
    • All Business
    • MarketsSharesCurrencyCommoditiesStock TakesCrypto
    • Markets with Madison
    • Media Insider
    • Business analysis
    • Personal financeKiwiSaverInterest ratesTaxInvestment
    • EconomyInflationGDPOfficial cash rateEmployment
    • Small business
    • Business reportsMood of the BoardroomProject AucklandSustainable business and financeCapital markets reportAgribusiness reportInfrastructure reportDynamic business
    • Deloitte Top 200 Awards
    • CompaniesAged CareAgribusinessAirlinesBanking and financeConstructionEnergyFreight and logisticsHealthcareManufacturingMedia and MarketingRetailTelecommunicationsTourism
  • Opinion
    • All Opinion
    • Analysis
    • Editorials
    • Business analysis
    • Premium opinion
    • Letters to the editor
  • Politics
  • Sport
    • All Sport
    • OlympicsParalympics
    • RugbySuper RugbyNPCAll BlacksBlack FernsRugby sevensSchool rugby
    • CricketBlack CapsWhite Ferns
    • Racing
    • NetballSilver Ferns
    • LeagueWarriorsNRL
    • FootballWellington PhoenixAuckland FCAll WhitesFootball FernsEnglish Premier League
    • GolfNZ Open
    • MotorsportFormula 1
    • Boxing
    • UFC
    • BasketballNBABreakersTall BlacksTall Ferns
    • Tennis
    • Cycling
    • Athletics
    • SailingAmerica's CupSailGP
    • Rowing
  • Lifestyle
    • All Lifestyle
    • Viva - Food, fashion & beauty
    • Society Insider
    • Royals
    • Sex & relationships
    • Food & drinkRecipesRecipe collectionsRestaurant reviewsRestaurant bookings
    • Health & wellbeing
    • Fashion & beauty
    • Pets & animals
    • The Selection - Shop the trendsShop fashionShop beautyShop entertainmentShop giftsShop home & living
    • Milford's Investing Place
  • Entertainment
    • All Entertainment
    • TV
    • MoviesMovie reviews
    • MusicMusic reviews
    • BooksBook reviews
    • Culture
    • ReviewsBook reviewsMovie reviewsMusic reviewsRestaurant reviews
  • Travel
    • All Travel
    • News
    • New ZealandNorthlandAucklandWellingtonCanterburyOtago / QueenstownNelson-TasmanBest NZ beaches
    • International travelAustraliaPacific IslandsEuropeUKUSAAfricaAsia
    • Rail holidays
    • Cruise holidays
    • Ski holidays
    • Luxury travel
    • Adventure travel
  • Kāhu Māori news
  • Environment
    • All Environment
    • Our Green Future
  • Talanoa Pacific news
  • Property
    • All Property
    • Property Insider
    • Interest rates tracker
    • Residential property listings
    • Commercial property listings
  • Health
  • Technology
    • All Technology
    • AI
    • Social media
  • Rural
    • All Rural
    • Dairy farming
    • Sheep & beef farming
    • Horticulture
    • Animal health
    • Rural business
    • Rural life
    • Rural technology
    • Opinion
    • Audio & podcasts
  • Weather forecasts
    • All Weather forecasts
    • Kaitaia
    • Whangārei
    • Dargaville
    • Auckland
    • Thames
    • Tauranga
    • Hamilton
    • Whakatāne
    • Rotorua
    • Tokoroa
    • Te Kuiti
    • Taumaranui
    • Taupō
    • Gisborne
    • New Plymouth
    • Napier
    • Hastings
    • Dannevirke
    • Whanganui
    • Palmerston North
    • Levin
    • Paraparaumu
    • Masterton
    • Wellington
    • Motueka
    • Nelson
    • Blenheim
    • Westport
    • Reefton
    • Kaikōura
    • Greymouth
    • Hokitika
    • Christchurch
    • Ashburton
    • Timaru
    • Wānaka
    • Oamaru
    • Queenstown
    • Dunedin
    • Gore
    • Invercargill
  • Meet the journalists
  • Promotions & competitions
  • OneRoof property listings
  • Driven car news

Puzzles & Quizzes

  • Puzzles
    • All Puzzles
    • Sudoku
    • Code Cracker
    • Crosswords
    • Cryptic crossword
    • Wordsearch
  • Quizzes
    • All Quizzes
    • Morning quiz
    • Afternoon quiz
    • Sports quiz

Regions

  • Northland
    • All Northland
    • Far North
    • Kaitaia
    • Kerikeri
    • Kaikohe
    • Bay of Islands
    • Whangarei
    • Dargaville
    • Kaipara
    • Mangawhai
  • Auckland
  • Waikato
    • All Waikato
    • Hamilton
    • Coromandel & Hauraki
    • Matamata & Piako
    • Cambridge
    • Te Awamutu
    • Tokoroa & South Waikato
    • Taupō & Tūrangi
  • Bay of Plenty
    • All Bay of Plenty
    • Katikati
    • Tauranga
    • Mount Maunganui
    • Pāpāmoa
    • Te Puke
    • Whakatāne
  • Rotorua
  • Hawke's Bay
    • All Hawke's Bay
    • Napier
    • Hastings
    • Havelock North
    • Central Hawke's Bay
    • Wairoa
  • Taranaki
    • All Taranaki
    • Stratford
    • New Plymouth
    • Hāwera
  • Manawatū - Whanganui
    • All Manawatū - Whanganui
    • Whanganui
    • Palmerston North
    • Manawatū
    • Tararua
    • Horowhenua
  • Wellington
    • All Wellington
    • Kapiti
    • Wairarapa
    • Upper Hutt
    • Lower Hutt
  • Nelson & Tasman
    • All Nelson & Tasman
    • Motueka
    • Nelson
    • Tasman
  • Marlborough
  • West Coast
  • Canterbury
    • All Canterbury
    • Kaikōura
    • Christchurch
    • Ashburton
    • Timaru
  • Otago
    • All Otago
    • Oamaru
    • Dunedin
    • Balclutha
    • Alexandra
    • Queenstown
    • Wanaka
  • Southland
    • All Southland
    • Invercargill
    • Gore
    • Stewart Island
  • Gisborne

Media

  • Video
    • All Video
    • NZ news video
    • Herald NOW
    • Business news video
    • Politics news video
    • Sport video
    • World news video
    • Lifestyle video
    • Entertainment video
    • Travel video
    • Markets with Madison
    • Kea Kids news
  • Podcasts
    • All Podcasts
    • The Front Page
    • On the Tiles
    • Ask me Anything
    • The Little Things
  • Cartoons
  • Photo galleries
  • Today's Paper - E-editions
  • Photo sales
  • Classifieds

NZME Network

  • Advertise with NZME
  • OneRoof
  • Driven Car Guide
  • BusinessDesk
  • Newstalk ZB
  • Sunlive
  • ZM
  • The Hits
  • Coast
  • Radio Hauraki
  • The Alternative Commentary Collective
  • Gold
  • Flava
  • iHeart Radio
  • Hokonui
  • Radio Wanaka
  • iHeartCountry New Zealand
  • Restaurant Hub
  • NZME Events

SubscribeSign In
Advertisement
Advertise with NZME.
Home / New Zealand

Test drug contributed to death

APNZ
1 Aug, 2012 06:48 AM4 mins to read

Subscribe to listen

Access to Herald Premium articles require a Premium subscription. Subscribe now to listen.
Already a subscriber?  Sign in here

Listening to articles is free for open-access content—explore other articles or learn more about text-to-speech.
‌
Save

    Share this article

File photo / Thinkstock

File photo / Thinkstock

An unapproved drug taken as part of a medical study contributed to the death of a Christchurch man who was hit while riding his scooter home, a coroner has found.

John MacDonald, 59, had been taking part in a clinical trial comparing a new blood thinner with standard treatment at the time of the incident.

His direct cause of death was cardio respiratory arrest, but he suffered significant chest injuries and an unusually "enormous blood loss" following the crash caused by the drug he had been taking to thin his blood, Coroner Sue Johnson found.

The tenancy liaison officer was on his way home from work about 5pm on December 9, 2009 when he was hit by a car.

He was rushed to Christchurch Hospital but died almost six hours later.

Advertisement
Advertise with NZME.
Advertisement
Advertise with NZME.

A post-mortem examination found he died "most probably due to hypovolaemic shock - an emergency condition in which severe blood and fluid loss make the heart unable to pump enough blood to the body".

Mr MacDonald was one of 14,200 international participants taking part in the medical trial by Bayer Health Care, which manufactures a blood thinning drug called rivaroxaban.

In New Zealand and Australia Johnson & Johnson Pharmaceutical Research and Development conducted the trials, which had been approved by the Health Research Council and and an accredited ethics committee.

Advertisement
Advertise with NZME.

Participants were randomly blindly assigned to take one of two blood thinning treatments, rivaroxaban or warfarin, which can both cause "major bleeding", said the finding.

Because of his irregular heart rhythm, MacDonald met the study criteria and was invited to take part. A complication of his condition was the formation of blood clots, which can be treated by using an anticoagulant - blood thinner.

As part of the trial he was given information that included the warning rivaroxaban could increase the risk of bleeding.

In case of emergency participants were given a medic alert bracelet, wallet card with study details and contact number and it was added to patients' clinical notes.

Discover more

New Zealand

Stroke treatment breakthrough by Kiwi scientists

03 Aug 03:22 AM
New Zealand

Amendment made to coroner's finding

09 Sep 12:50 AM

On December 9, Mr MacDonald was travelling in a cycle lane behind a car when the driver "indicated for a couple of seconds before pulling to the left", according to a witness.

Mr MacDonald swerved left but was hit by the car, sending him off his scooter.

After the crash he told a paramedic he was taking a blood thinner as part of a medical trial but did not know which one and was rushed to hospital, in a stable condition.

The doctor treating him had not heard of rivaroxaban at the time which meant he "did not know that Mr MacDonald's blood might not clot normally and that it was thinned", said the finding.

Mr MacDonald was given blood and saline over the next four hours but bled profusely and became increasingly unstable.

At 9.15pm he went into cardiac arrest and became unconscious. Staff attempted resuscitation, but he died 90 minutes later.

Advertisement
Advertise with NZME.

In spite of the plans in place to notify medical staff of Mr MacDonald's participation in the trial, hospital staff remained unaware because they did not know clinical notes had arrived in ED, the emergency number on the medic alert bracelet was unavailable and ED staff did not see the wallet card, said the finding.

"I thus find had Dr Pearson known Mr MacDonald was or might have been on rivaroxaban, there was a chance his significant coagulopathy could perhaps have been reversed to some extent, but this chance was lost because Dr Pearson did not know," said Coroner Johnson.

"I thus find that Mr MacDonald's participation in the trial and being on the rivaroxaban arm of it contributed to his death."

Following a review by Christchurch Hospital since his death details on patients enrolled in trials is placed on a patient information system for medical staff but there were ongoing issues around consistency, an investigator found

Coroner Johnson also supported a number of other recommendations made in the review including, providing advice to trial participants about the effects of rivaroxaban, a back-up local contact system, and procedures around making written notes available.

She recommended information about trials of new medicines are made immediately accessible to all emergency department staff.

Advertisement
Advertise with NZME.
Save

    Share this article

Latest from New Zealand

Auckland

Woman traumatised after alleged gang rape by men she met at Ponsonby bar, two charged

02 Jul 05:31 AM
Premium
PoliticsUpdated

New visa: Why Ministers were warned over migrant numbers, health system impact

02 Jul 05:29 AM
New Zealand|crime

Migrant worker allegedly beaten for demanding unpaid wages, man faces serious assault charge

02 Jul 05:22 AM

There’s more to Hawai‘i than beaches and buffets – here’s how to see it differently

sponsored
Advertisement
Advertise with NZME.

Latest from New Zealand

Woman traumatised after alleged gang rape by men she met at Ponsonby bar, two charged

Woman traumatised after alleged gang rape by men she met at Ponsonby bar, two charged

02 Jul 05:31 AM

The men were granted bail and have a curfew from 7pm to 7am.

Premium
New visa: Why Ministers were warned over migrant numbers, health system impact

New visa: Why Ministers were warned over migrant numbers, health system impact

02 Jul 05:29 AM
Migrant worker allegedly beaten for demanding unpaid wages, man faces serious assault charge

Migrant worker allegedly beaten for demanding unpaid wages, man faces serious assault charge

02 Jul 05:22 AM
From the theatre to a line mechanic: Hastings woman aims to inspire women into electrical trade

From the theatre to a line mechanic: Hastings woman aims to inspire women into electrical trade

02 Jul 04:05 AM
From early mornings to easy living
sponsored

From early mornings to easy living

NZ Herald
  • About NZ Herald
  • Meet the journalists
  • Newsletters
  • Classifieds
  • Help & support
  • Contact us
  • House rules
  • Privacy Policy
  • Terms of use
  • Competition terms & conditions
  • Our use of AI
Subscriber Services
  • NZ Herald e-editions
  • Daily puzzles & quizzes
  • Manage your digital subscription
  • Manage your print subscription
  • Subscribe to the NZ Herald newspaper
  • Subscribe to Herald Premium
  • Gift a subscription
  • Subscriber FAQs
  • Subscription terms & conditions
  • Promotions and subscriber benefits
NZME Network
  • The New Zealand Herald
  • The Northland Age
  • The Northern Advocate
  • Waikato Herald
  • Bay of Plenty Times
  • Rotorua Daily Post
  • Hawke's Bay Today
  • Whanganui Chronicle
  • Viva
  • NZ Listener
  • Newstalk ZB
  • BusinessDesk
  • OneRoof
  • Driven Car Guide
  • iHeart Radio
  • Restaurant Hub
NZME
  • About NZME
  • NZME careers
  • Advertise with NZME
  • Digital self-service advertising
  • Book your classified ad
  • Photo sales
  • NZME Events
  • © Copyright 2025 NZME Publishing Limited
TOP